New Type of Cancer Immunotherapeutic Approved by FDA: What It Means for Leukemia Patients
Earlier this month we witnessed another leap forward for immunotherapy when the FDA approved blinatumomab (Blincyto) for the treatment...
Earlier this month we witnessed another leap forward for immunotherapy when the FDA approved blinatumomab (Blincyto) for the treatment...
The summer issue of Cancer Today is out and features stories on the challenge of having both cancer and...